Health
Moderna Starts Final-Phase Testing For Coronavirus Vaccine; Stock Jumps – Investor’s Business Daily
Moderna has started a phase 3 trial for its coronavirus vaccine, as it races with AstraZeneca, Pfizer and others. MRNA stock jumped.
Moderna announced early Monday the start of the crucial final testing phase for its much-heralded coronavirus vaccine. MRNA stock jumped in morning trades.
XModerna (MRNA) is racing to develop a coronavirus vaccine in what could be record time, along with a bevy of rivals also seeking to end the Covid-19 pandemic with a safe, effective vaccine.
AstraZeneca (AZN) and partner Oxford University have already begun Phase 3 testing for its coronavirus vaccine candidate. Dow giant Pfizer (PFE), with …
Continue Reading